Mr James Beswick

View graph of relations

Publications

  1. 2020
  2. Accepted/In press

    LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation

    Green, J., Swanton, T., Morris, L., El-Sharkawy, L., Cook, J., Yu Shi, A., Beswick, J., Adamson, A., Humphreys, N., Bryce, R., Freeman, S., Lawrence, C. B. & Brough, D., 21 Oct 2020, (Accepted/In press) In : eLife.

    Research output: Contribution to journalArticlepeer-review

  3. E-pub ahead of print

    Selective inhibition of the K+ efflux sensitive NLRP3 pathway by Cl- channel modulation

    Swanton, T., Beswick, J., Hammadi, H., Morris, L., Williams, D., De Cesco, S., El-sharkawy, L., Yu, S., Green, J., Davis, J., Lawrence, C., Brough, D. & Freeman, S., 12 Oct 2020, In : Chemical Science.

    Research output: Contribution to journalArticlepeer-review

  4. 2018
  5. Published

    Design, Synthesis and Evaluation of Novel Oxazaborine Inhibitors of the NLRP3 Inflammasome

    Baldwin, A., Tapia Olivares, V., Swanton, T., White, C., Beswick, J., Brough, D. & Freeman, S., 2018, In : ChemMedChem.

    Research output: Contribution to journalArticlepeer-review

  6. Published

    Is targeting the inflammasome a way forward for neuroscience drug discovery?

    Swanton, T., Cook, J., Beswick, J., Freeman, S., Lawrence, C. B. & Brough, D., 2018, In : SLAS Discovery.

    Research output: Contribution to journalArticlepeer-review

Research Explorer downloads

79

Research output: Contribution to journalArticlepeer-review